Somatostatin and cognitive functions in Alzheimer's disease — the relationship of cerebrospinal fluid somatostatin increase with clinical response to tetrahydroaminoacridine
- 2 September 1991
- journal article
- Published by Elsevier in Neuroscience Letters
- Vol. 130 (1) , 46-48
- https://doi.org/10.1016/0304-3940(91)90223-g
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Discrimination of tetrahydroaminoacridine responders by a single dose pharmaco-EEG in patients with Alzheimer's diseaseNeuroscience Letters, 1991
- Evidence that Somatostatin Enhances Endogenous Acetylcholine Release in the Rat HippocampusJournal of Neurochemistry, 1990
- Influence of Tetrahydro-9-Aminoacridine on Excitatory Amino Acid ReleaseClinical Neuropharmacology, 1990
- Somatostatin content and release measured in cerebral biopsies from demented patientsJournal of the Neurological Sciences, 1987
- Decreased somatostatin-like immunoreactivity in cerebral cortex and cerebrospinal fluid in Alzheimer's diseaseBrain Research, 1987
- Heterogeneity in dementia of the Alzheimer typeNeurology, 1985
- Somatostatin immunoreactivity in neuritic plaques of Alzheimer's patientsNature, 1985
- Somatostatin release from cerebral cortical cells: influence of amino acid neurotransmittersBrain Research, 1983
- Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementaNature, 1980
- “Mini-mental state”Journal of Psychiatric Research, 1975